Published in Gene Therapy Weekly, January 11th, 2001
Researchers in The Netherlands created a recombinant Semliki Forest virus (SFV) vector that expresses the human papillomavirus (HPV) proteins, E6 and E7. Expression of E6 and E7, they explained, is key to the transforming potential of HPV-16 and HPV-18, strains linked to development of cervical cancer via infection of genital epithelial cells.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.